The CK2 holoenzyme is composed of two catalytic subunits (CK2α and/or CK2α') and two regulatory CK2β subunits while the catalytic subunits can catalyze hundreds substrates and participates in complex cancer regulation networks [16]. Here, CSNK2B is linked to cancer.